EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations

Muna Shakhashiro iD, Shadi Sadeghian, Jack Newcomer iD, Angelo Valerio Marzano iD, Carlo Alberto Maronese iD, John M Davis, Afsaneh Alavi

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Muna Shakhashiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky College of Medicine, Lexington, KY, USA. Hauptthemen laut MEDLINE: Arthritis, Hereditary Autoinflammatory Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yao syndrome (YAOS) is a novel systemic autoinflammatory disease linked to the nucleotide‐binding oligomerization domain (NOD2) gene. It is characterized by periodic fevers, gastrointestinal (GI) symptoms, arthritis, and dermatitis, among other symptoms. A sparse literature exists on this disease, and little is known about its dermatological manifestations. A review of available literature was performed to characterize the cutaneous manifestations of Yao syndrome. Cutaneous manifestations were documented in 85.7% of patients, with common characteristic descriptions of erythematous patches and plaques involving the face, trunk, abdomen, and extremities. Based on our review of treatment modalities employed for Yao syndrome, prednisone is an appropriate initial approach, with oral sulfasalazine and other disease‐modifying antirheumatic drugs serving as appropriate secondary options. YAOS should be considered in the differential diagnosis of patients presenting with a dermatitic rash, especially in the context of concurrent articular symptoms, periodic fever, and GI symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArthritisHereditary Autoinflammatory DiseasesHumansNod2 Signaling Adaptor ProteinFeverSyndromeSulfasalazinePrednisoneDermatitisAntirheumatic AgentsGastrointestinal Diseases

Stichwörter der Autor:innen

NOD2Yao syndromeautoinflammatory diseasecutaneous manifestationsnarrative review

Substanzen

Nod2 Signaling Adaptor ProteinSulfasalazineNOD2 protein, humanPrednisoneAntirheumatic AgentsYao syndrome

Autor:innen und Institutionen

  • University of Kentucky College of Medicine, Lexington, KY, USA.
  • Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
  • Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
  • Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Muna Shakhashiro, Jack Newcomer, Angelo Valerio Marzano, Carlo Alberto Maronese

Zitieren

APA

Shakhashiro, M., Sadeghian, S., Newcomer, J., Marzano, A. V., Maronese, C. A., Davis, J. M., & Alavi, A. (2025). Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations. International Journal of Dermatology. https://doi.org/10.1111/ijd.17350

Vancouver

Shakhashiro M, Sadeghian S, Newcomer J, Marzano AV, Maronese CA, Davis JM, et al. Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations. International Journal of Dermatology. 2025. doi:10.1111/ijd.17350

BibTeX
@article{Shakhashiro2025,
  author = {Shakhashiro, Muna and Sadeghian, Shadi and Newcomer, Jack and Marzano, Angelo Valerio and Maronese, Carlo Alberto and Davis, John M and Alavi, Afsaneh},
  title = {Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17350}
}
Kostenlos starten →